3 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow lanreotide: new trials by email Literature Review of lanreotide trials Research Report on lanreotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma Gamma knife radiosurgery, Lanreotide 60Mg Solution for Injection - Acromegaly Due to Pituitary Adenoma | Phase 3 | Unknown | Samsung Medical Center | 90 | 2018-03-01 | 2018-03-01 |
| Study of Lanreotide to Treat Polycystic Kidney Disease Lanreotide - Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 3 | Unknown | University Medical Center Groningen | 300 | 2012-06-01 | 2017-05-23 |
| Open-Label Extension of LOCKCYST Trial lanreotide - Polycystic Liver Disease, Hepatomegaly | Phase 2 / Phase 3 | Unknown | Radboud University Medical Center | 54 | 2008-04-01 | 2008-11-13 |
Polycystic Kidney Diseases (2) · Polycystic liver disease (2) · Acromegaly (1) · Growth Hormone-Secreting Pituitary Adenoma (1) · Hepatomegaly (1) · Liver Diseases (1) · Multiple Pterygium Syndrome, Autosomal Dominant (1) · Pituitary Neoplasms (1) · Polycystic Kidney, Autosomal Dominant (1)
Radboud University Medical Center (1) · Samsung Medical Center (1) · University Medical Center Groningen (1)
Netherlands (2) · Belgium (1) · South Korea (1)
Frederik Nevens, MD, PhD (1) · Joost PH Drenth, PhD (1) · Loes van Keimpema, MSc (1) · Ron Gansevoort, MD, PhD (1)
PMID 27995519, PMID 30422235, PMID 31022403, PMID 33779943, PMID 39356039